MERTK and non-small cell lung carcinoma: Strikingly, MERTK, known to be involved in immunotolerance and activating oncogenic signaling pathways,21,22 was the only protein significantly higher on CD1c+CD14+ cells of NSCLC patients compared with HDs (Figure 1F).